{"version":"1.0","type":"link","title":"Acquired CCDC6-RET Fusion After First-Line Osimertinib in Epidermal Growth Factor Receptor (EGFR)-Mutant Lung Adenocarcinoma: A Case Report.","author_name":"Afonso ARS 외","author_url":"https://prs-insight.online/author/Afonso%20ARS","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/98630","thumbnail_width":1200,"thumbnail_height":630}